Clinical Investigation for Safety and Efficacy Study of CELT ACD (Arterial ClosureDevice)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 241 participants.

Also called NCT01600482

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 241 participants (enrolled count) (from the registry)
Sponsor
Vasorum Ltd (from the registry)
Registry
  • NCT NCT01600482
Other papers using this trial's data
  • A multicenter randomized trial comparing the effectiveness and safety of a novel vascular closure device to manual compression in anticoagulated patients undergoing percutaneous transfemoral procedures: The CELT ACD trial Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2017-11-01 DOI, PubMed 28296003

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Germany, Ireland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01600482. Randomized; no masking; primary purpose supportive care. Start 2012-05 (registry gives no type); primary completion 2016-02 (actual). Results posted on 2017-08-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Investigation for Safety and Efficacy Study of CELT ACD (Arterial ClosureDevice)
Condition
Cardiac Disease
Intervention (Device)
CELT ACD
Lead sponsor
Vasorum Ltd (class: industry)

Record details

Record id
cardio:ct-nct01600482
Content hash
4a9bd3378dccc85a9db35d6074998c4c1c30146ebdecdbce65f4bd160fe892df